Showing results (441-450 of 2,992) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|January 1, 1991
Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparinsH L Messmore, B Griffin, M Koza, et al.Seminars in Thrombosis and Hemostasis|July 17, 2007
Structural modification induced in heparin by a Fenton-type depolymerization processElena Vismara, Monica Pierini, Sara Guglieri, et al.Seminars in Thrombosis and Hemostasis|July 17, 2007
Measurement of maximum thrombin generation capacity in blood and plasma using the thrombin generation assay (THROGA)Götz Nowak, Ute Lange, Annett Wiesenburg, et al.Seminars in Thrombosis and Hemostasis|July 17, 2007
Affinity and kinetics of different heparins binding to P- and L-selectinDirk Simonis, Katrin Christ, Susanne Alban, et al.Seminars in Thrombosis and Hemostasis|July 17, 2007
Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasisLubor BorsigSeminars in Thrombosis and Hemostasis|July 17, 2007
O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasisMarjut Borgenström, Anni Wärri, Katri Hiilesvuo, et al.Seminars in Thrombosis and Hemostasis|January 1, 1991
Pathophysiology of venous thromboembolismH K NielsenSeminars in Thrombosis and Hemostasis|May 26, 2007
Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular riskTiziano Barbui, Guido FinazziSeminars in Thrombosis and Hemostasis|May 26, 2007
The double hazard of thrombophilia and bleeding in acute promyelocytic leukemiaMartin S Tallman, Syed A Abutalib, Jessica K AltmanSeminars in Thrombosis and Hemostasis|May 26, 2007
Adverse effects on hemostatic function of drugs used in hematologic malignanciesAnaadriana Zakarija, Hau C KwaanPageof 300